与牛皮和牛皮性关节炎相关的生物标志物和生物制剂
Weize Gao1, Zhan Wang1, Wenshuai Li1
1Department of Clinical Laboratory, Key Laboratory of Laboratory Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.
International immunopharmacology
|July 16, 2023
概括
识别新的生物标志物对于管理牛皮,一种免疫介导的皮肤疾病至关重要. 这项研究审查了生物标志物和生物疗法,以改善患者的治疗结果和治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 类风湿病学 类风湿病学
背景情况:
- 牛皮是一种免疫介导的炎症性皮肤疾病,具有自身免疫和自身炎症特征.
- 目前的治疗方法旨在控制症状并改善生活质量,因为目前还没有治愈方法.
- 发现生物标志物对于预测,监测和开发新的治疗点至关重要.
研究的目的:
- 系统地审查有关牛皮相关生物标志物的研究进展.
- 详细阐述这些生物标志物的机制在牛皮和牛皮关节炎的发病.
- 总结了牛皮和牛皮性关节炎的生物疗法的进展.
主要方法:
- 关于牛皮生物标志物的科学文献的系统审查.
- 对生物标志物参与疾病病理学的机制的分析.
- 收集有关当前和新兴生物疗法的数据.
主要成果:
- 在识别与牛皮相关的众多生物标志物方面取得了重大进展.
- 生物标志物在牛皮和牛皮性关节炎的病理发展中发挥着关键作用.
- 生物疗法在治疗牛皮和牛皮性关节炎方面表现有前途.
结论:
- 生物标志物对于促进了解和临床治疗牛皮至关重要.
- 对生物标志物的进一步研究可以导致新的治疗目标和改进的治疗策略.
- 牛皮越来越被认为是一种复杂的免疫媒介炎症性疾病.
更多相关视频
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
121
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
121
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
175
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
175
Inflammatory Bowel Disease IV: Pharmacological Management
154
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
154
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
198
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
198


